Eupraxia Pharmaceuticals

Forecast & Rating12 analysts currently cover Eupraxia Pharmaceuticals, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $16.61, about 141.8% upside from the current price of $6.87. Price targets range from $11.00 to $25.00 — a wide spread, showing clear disagreement over just how much Eupraxia Pharmaceuticals can rise. For you, this means most professionals who study Eupraxia Pharmaceuticals closely still see room for the stock to rise. Data as of Oct 23, 2026; for reference only and not investment advice.